Dicerna Pharmaceuticals Inc
DRNADelisted Dec 28, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001399529
Dicerna Pharmaceuticals Inc was delisted on Dec 28, 2021; its insiders filed their last Form 4 on Dec 29, 2021; 173 institutions reported holding it in 13F filings for Q3 2021, worth $1.28B in total; Maverick Capital was the only superinvestor holding it.
Holders of 5% or more of DRNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Dicerna Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Dicerna Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Dicerna Pharmaceuticals Inc, newest first.
No Schedule 13D or 13G filings on Dicerna Pharmaceuticals Inc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Dicerna Pharmaceuticals Inc shares.
No Form 144 notices for Dicerna Pharmaceuticals Inc are on file.